Genflow Biosciences (LON:GENF) Releases Earnings Results

Genflow Biosciences (LON:GENF) released its earnings results on Thursday. The company reported GBX (0.33) EPS for the quarter, Digital Look Earnings reports. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.

Genflow Biosciences Price Performance

Shares of GENF traded down GBX 0.03 during mid-day trading on Thursday, reaching GBX 2.77. 3,763,003 shares of the company’s stock traded hands, compared to its average volume of 2,702,674. The stock has a market cap of £14.84 million, a P/E ratio of -5.52 and a beta of 2.11. The stock’s 50-day moving average is GBX 2.04 and its two-hundred day moving average is GBX 1.97. Genflow Biosciences has a 12 month low of GBX 0.55 and a 12 month high of GBX 3.12.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.